Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival

€6.94M EUR

Funder	European Commission
Recipient Organization	Fundacion Privada Instituto de Salud Global Barcelona
Country	Spain
Start Date	Sep 01, 2022
End Date	Aug 31, 2027
Duration	1,825 days
Number of Grantees	12
Roles	Participant; Associated Partner; Coordinator
Data Source	European Commission
Grant ID	`101057114`

Grant Description

Fever is the leading reason to seek healthcare globally, with over 1 billion cases of febrile illness occurring in children annually. The vast majority of infections are uncomplicated and self-limited and can be treated conservatively. A few (

All Grantees

Fundacao Manhica; London School of Hygiene & Tropical Medicine; Fundacion Privada Instituto de Salud Global Barcelona; Bioeclosion Sl; Asphalion Sl; Universitat Autonoma de Barcelona; Fundacio Eurecat; Eberhard Karls Universitaet Tuebingen; Centre de Recherches Medicales de Lambaréné; Ospedale Pediatrico Bambino Gesu; University Health Network